|
Name |
Type |
Discontinued? |
|
| 1 |
RESULT_ID |
VARCHAR |
No |
|
|
|
| The unique identifier for the result record. |
|
|
| 2 |
TUMOR_SITE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify tumor site. |
|
|
| 3 |
CAP_COMMENTS |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: General comments. |
|
|
| 4 |
SPEC_PROC_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify the Specimen Procedure. |
|
|
| 5 |
TUMOR_SIZE_GREAT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Greatest Size. |
|
|
| 6 |
TUMOR_SIZE_ADDL |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (length). |
|
|
| 7 |
TUMOR_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (width). |
|
|
| 8 |
TUMOR_SIZE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Tumor Size. |
|
|
| 9 |
HISTO_TYPE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify histologic type. |
|
|
| 10 |
MARGIN_UNITS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margin Units. |
| May contain organization-specific values: Yes |
| Category Entries: |
| mm |
| cm |
|
|
| 11 |
SPECIFIC_MARGINS |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specific Margins. |
|
|
| 12 |
DISTNT_METASTASIS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Distant Metastasis. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| cM0 (i+): No clinical or radiographic evidence of distant metastasis |
| pM0: No distant metastasis |
| pM1: Distant metastasis |
| pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx |
| pM1b: Nonperitoneal metastasis |
| pM1: Distant detectable metastasis as determined by classic clinical |
| pM1 (IVB): Distant metastasis |
| pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or |
| pM1b: Distant metastases outside the lung / pleura |
| pM1: Distant metastasis (documented in this specimen) |
| pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes |
| pM1b: Metastasis to lung |
| pM1c: Metastasis to all other visceral sites or distant metastasis at any site |
| pM1a: Nonregional lymph node(s) |
| pM1b: Bone(s) |
| pM1c: Other site(s) with or without bone disease |
| pM1: Metastasis to sites other than CNS |
| pM1a: Single lesion |
| pM1b: Multiple lesions |
| pM1c: CNS metastasis |
| pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement |
| pM1e: Leptomeningeal and / or CSF involvement |
| pM1a: Non-regional lymph nodes or pulmonary metastasis |
| pM1b: Distant metastasis other than to nonregional lymph nodes and lungs |
| pM1a (III): Tumor extends to the lungs with or without genital tract involvement |
| pM1b (IV): Tumor involves other metastatic sites |
| pM1a: Largest diameter of the largest metastasis 3 cm or less |
| pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm |
| pM1c: Largest diameter of the largest metastasis 8 cm or more |
| pM1a: Lung |
| pM1b: Metastasis involving distant sites other than lung (including skip metastases) |
| Distant Metastasis present (includes metastasis to lymph nodes) |
|
|
| 13 |
DSTNT_METASTATIS_ST |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Distant Metastasis Sites. |
|
|
| 14 |
ADDL_PATH_FIND_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify additional pathologic findings. |
|
|
| 15 |
SPEC_PROC_AMPU_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specimen Procedure Amputation Specify. |
|
|
| 16 |
ALVEOLAR_PERCENTAGE |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Histologic Type Percentage of Alveolar. |
|
|
| 17 |
EMBRYONAL_PERCENT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Histologic Type Percentage of Embryonal. |
|
|
| 18 |
SOFT_TISSUE_TMR_SP |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Depth for Soft Tissue-Based Tumors Specify. |
|
|
| 19 |
ANAPLASIA_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Anaplasia. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not identified |
| Focal (single or few scattered anaplastic cells) |
| Diffuse (clusters or sheets of anaplastic cells) |
| Indeterminate |
| Cannot be assessed |
|
|
| 20 |
RHABDOMYO_GRP_SYS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| Cannot be assessed |
|
|
| 21 |
RHABDOMY_GRP_SYS_SP |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System Specify. |
|
|
| 22 |
STAGING_RHABDOMYO_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Modified Site, Size, Metastasis Staging for Rhabdomyosarcoma (for relevant stage). |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| Cannot be assessed |
| Stage I |
| Stage II |
| Stage III |
| Stage IV |
|
|
| 23 |
RHABDOM_STAGE_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Modified Site, Size, Metastasis Staging for Rhabdomyosarcoma Specify. |
|
|
| 24 |
DIST_SARCOMA_MARGIN |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Distance of Sarcoma from Closest Margin. |
|
|
| 25 |
LYMPH_ND_NUM_XMD |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Specify the number of lymph nodes examined. |
|
|
| 26 |
LYM_ND_NUM_IVLV |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Specify number of lymph nodes involved. |
|
|
| 27 |
NO_REGION_LYMPH_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Lymph Nodes No Regional Lymph Nodes. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Metastatic involvement of regional lymph nodes not identified |
| Regional lymph node metastasis present |
|
|
| 28 |
RHAB_GRP_SYS_I_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System Group I. |
| May contain organization-specific values: Yes |
| Category Entries: |
| A Localized tumor, confined to site of origin, completely resected |
| B Localized tumor, infiltrating beyond site of origin, completely resected |
|
|
| 29 |
RHAB_GRP_SYS_II_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System Group II. |
| May contain organization-specific values: Yes |
| Category Entries: |
| A Localized tumor, gross total resection, but with microscopic residual disease |
| B Locally extensive tumor (spread to regional lymph nodes), completely resected |
| C locally extensive tmr, gross total resection, but microscopic residual disease |
|
|
| 30 |
RHAB_GRP_SYS_III_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System Group III. |
| May contain organization-specific values: Yes |
| Category Entries: |
| A Localized or locally extensive tumor, gross residual disease after biopsy only |
| B Localized or locally extensive tumor, gross residual disease after major resection |
|
|
| 31 |
RHAB_GRP_SYS_IV_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System Group IV. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Any size primary tumor, with or without regional lymph node, with distant metastases |
|
|
